Drugs and Devices

FDA approves new drug for osteoporosis

On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at high risk of fractures.

Read more here.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares